These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 7773578)

  • 1. Sepsis and septic shock. II. Treatment.
    Mayer J; Hajek R; Vorlicek J; Tomiska M
    Support Care Cancer; 1995 Mar; 3(2):111-9. PubMed ID: 7773578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies for sepsis and septic shock.
    Oh HM
    Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock.
    Spapen HD; Diltoer M; Huyghens LP
    Acta Clin Belg; 1993; 48(1):20-9. PubMed ID: 7684546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy of sepsis and septic shock].
    Ivanović D; Gjurasin M; Gasparović V; Radonić R; Kvarantan M; Merkler M
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():8-11. PubMed ID: 8649167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock.
    Vincent JL; Sun Q; Dubois MJ
    Clin Infect Dis; 2002 Apr; 34(8):1084-93. PubMed ID: 11914997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis and septic shock. I. Definitions and pathophysiology.
    Mayer J; Hajek R; Vorlicek J; Tomiska M
    Support Care Cancer; 1995 Mar; 3(2):106-10. PubMed ID: 7773577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel potential therapies for septic shock.
    Azevedo LC; Park M; Schettino GP
    Shock; 2008 Oct; 30 Suppl 1():60-6. PubMed ID: 18704007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategies for combatting sepsis: the magic bullets missed the mark ... but the search continues.
    Quezado ZM; Banks SM; Natanson C
    Trends Biotechnol; 1995 Feb; 13(2):56-63. PubMed ID: 7765996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier.
    Rivers EP; Jaehne AK; Nguyen HB; Papamatheakis DG; Singer D; Yang JJ; Brown S; Klausner H
    Shock; 2013 Feb; 39(2):127-37. PubMed ID: 23324881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present possibilities of therapy of septic shock in surgical patients].
    Vyhnánek F; Lochmann O
    Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 42(3):105-15. PubMed ID: 1339601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of immunoglobulins in the treatment of patients with sepsis and septic shock.
    Bojić I; Begović V; Trnjak Z; Dokić M
    Vojnosanit Pregl; 1998; 55(2 Suppl):75-8. PubMed ID: 9623363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of sepsis.
    Evans TJ; Cohen J
    J Med Microbiol; 1993 Apr; 38(4):237-9. PubMed ID: 8474114
    [No Abstract]   [Full Text] [Related]  

  • 13. The Effect of Early Goal-Directed Therapy on Outcome in Adult Severe Sepsis and Septic Shock Patients: A Meta-Analysis of Randomized Clinical Trials.
    Xu JY; Chen QH; Liu SQ; Pan C; Xu XP; Han JB; Xie JF; Huang YZ; Guo FM; Yang Y; Qiu HB
    Anesth Analg; 2016 Aug; 123(2):371-81. PubMed ID: 27049857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathophysiological and intensive care-resuscitation aspects of septic shock].
    Vasilev D; Karadimov D
    Khirurgiia (Sofiia); 1996; 49(4):9-11. PubMed ID: 8968133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic markers of sepsis and septic shock].
    Kübler-Kiełb J; Adamik B
    Postepy Hig Med Dosw; 2000; 54(2):119-32. PubMed ID: 10857376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early outcome of early-goal directed therapy for patients with sepsis or septic shock: a systematic review and meta-analysis of randomized controlled trials.
    Chen X; Zhu W; Tan J; Nie H; Liu L; Yan D; Zhou X; Sun X
    Oncotarget; 2017 Apr; 8(16):27510-27519. PubMed ID: 28460438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Goal-Directed Therapy in Severe Sepsis and Septic Shock: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
    Lu Y; Zhang H; Teng F; Xia WJ; Sun GX; Wen AQ
    J Intensive Care Med; 2018 May; 33(5):296-309. PubMed ID: 27756870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the research of early goal-directed therapy in severe sepsis and septic shock].
    Sun W; Yuan H; An Y
    Zhonghua Shao Shang Za Zhi; 2016 May; 32(5):289-92. PubMed ID: 27188487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis criteria, and selection of patients for immunotherapy.
    Thijs LG
    Prog Clin Biol Res; 1994; 388():407-15. PubMed ID: 7831372
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems and perspective approaches to correction of mediator response in sepsis].
    Mironov PI; Rudnov VA
    Anesteziol Reanimatol; 1999; (3):54-9. PubMed ID: 10458039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.